Viewing Study NCT00926692


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2025-12-28 @ 5:47 AM
Study NCT ID: NCT00926692
Status: COMPLETED
Last Update Posted: 2015-08-26
First Post: 2009-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigations Regarding B-cell Subsets in Humans
Sponsor: Northwell Health
Organization:

Study Overview

Official Title: Investigations Regarding B-cell Subsets in Humans
Status: COMPLETED
Status Verified Date: 2015-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this research is to define the human equivalent of mouse B1 cells.
Detailed Description: The specific aim of this research project is to define the human equivalent of mouse B1 cells. This will be done by evaluating IgM secretion, surface markers, functional characteristics, V gene usage, N-region addition, and phosphorylation status of intracellular proteins, gene expression, sequencing of immunoglobulin genes, determination of antigenic specificity, replication history, and response to different stimuli.

The goal of this project is to begin to the translation of decades of basic science research and research in the mouse model into the human system. It is believed that properly defining this B cell subset in humans will lead to better therapeutics, prognostics and prevention for a number of disease including infections, autoimmune disease, and cancer.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: